how to activate glp-1 receptors Understanding receptor agonists and their impact on drug discovery GLP-1R and Diabetes

The FDA has approved three medications specifically for weight loss as of my preparation of this content: liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound) (National Institute of Diabetes and Digestive and Kidney Diseases, 2026b)

This information is for educational purposes and is not medical advice

These hepatic improvements, which may be associated with cotadutide's glucagon activity, indicate its potential as a therapeutic option for nonalcoholic steatohepatitis (NASH)

Monitor for Side Effects: GLP-1 agonists can cause a range of side effects, some of which may be more pronounced in individuals without diabetes